![](/img/cover-not-exists.png)
BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study
Fasching, Peter A., Loibl, Sibylle, Hu, Chunling, Hart, Steven N., Shimelis, Hermela, Moore, Raymond, Schem, Christian, Tesch, Hans, Untch, Michael, Hilfrich, Jörn, Rezai, Mahdi, Gerber, Bernd, Costa,Volume:
36
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2017.77.2285
Date:
August, 2018
File:
PDF, 809 KB
2018